FDA Approves Emergent BioSolutions Vaccine as New Tool in Fight Against Mpox

Emergent BioSolutions’ smallpox vaccine, ACAM2000, now has an additional FDA approval covering mpox. It’s one of two FDA-approved mpox vaccines, joining Jynneos from Bavarian Nordic. The post FDA Approves Emergent BioSolutions Vaccine as New Tool in Fight Against Mpox appeared first on MedCity News.